Addiction

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Aphios
AphiosMA - Woburn
1 program
1
APH-1501Phase 21 trial
Active Trials
NCT03813095UnknownEst. Dec 2025
Alliance Pharmaceuticals
1 program
First Face for Mental HeatlhN/A1 trial
Active Trials
NCT06290180Completed92Est. Apr 2025

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
AphiosAPH-1501
Alliance PharmaceuticalsFirst Face for Mental Heatlh

Clinical Trials (2)

Total enrollment: 92 patients across 2 trials

Exploratory Dose Ranging Study Assessing APH-1501 for the Treatment of Opioid Addiction

Start: Oct 2023Est. completion: Dec 2025
Phase 2Unknown
NCT06290180Alliance PharmaceuticalsFirst Face for Mental Heatlh

Healing Lodge First Face Training Evaluation Study

Start: Apr 2024Est. completion: Apr 202592 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space